Lower C-reactive protein level seen with self-monitoring program

03/8/2013 | PhysiciansBriefing.com

Data on 483 patients with poorly controlled, insulin-naive type 2 diabetes showed those in a structured intervention for self-monitoring of their blood glucose levels attained greater reductions in their level of high-sensitivity C-reactive protein at three, six and 12 months compared with those in the control group. The results appear in Diabetes Care.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA